Insider Transactions in Q4 2024 at Cytek Biosciences, Inc. (CTKB)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2024
|
Philippe Busque SVP, GLOBAL SALES AND SERVICES |
SELL
Payment of exercise price or tax liability
|
Direct |
1,460
-5.61%
|
$8,760
$6.03 P/Share
|
|
Nov 18
2024
|
Philippe Busque SVP, GLOBAL SALES AND SERVICES |
BUY
Exercise of conversion of derivative security
|
Direct |
3,746
+12.55%
|
-
|
|
Nov 18
2024
|
Allen Poirson SVP BUS. AND CORP. DEV. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-1.12%
|
$12,090
$6.03 P/Share
|
|
Nov 18
2024
|
Allen Poirson SVP BUS. AND CORP. DEV. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,171
+2.79%
|
-
|
|
Nov 18
2024
|
Wenbin Jiang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,897
-0.06%
|
$59,382
$6.03 P/Share
|
|
Nov 18
2024
|
Wenbin Jiang PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,639
+0.26%
|
-
|
|
Nov 18
2024
|
Valerie Barnett CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,499
-2.42%
|
$26,994
$6.03 P/Share
|
|
Nov 18
2024
|
Valerie Barnett CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,432
+6.64%
|
-
|
|
Nov 18
2024
|
Michael Holder |
BUY
Exercise of conversion of derivative security
|
Direct |
2,181
+37.5%
|
-
|
|
Nov 18
2024
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,622
-0.02%
|
$21,732
$6.03 P/Share
|
|
Nov 18
2024
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,869
+0.08%
|
-
|